LAMIVUDINE
20 NDCs across 10 manufacturers|17 Generic,3 Brand
Total NDCs
20
17G / 3B
Manufacturers
10
competing in market
Price Spread
$0.24 – $13.29
Up to 98% savings
7d Activity
12↑10↓-2 flat
of 20 total NDCs
Market Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
10 manufacturers producing LAMIVUDINE
ViiV Healthcare Company
3 NDCs
$6.7845
avg/unit
Apotex Corp.
3 NDCs
$3.5829
avg/unit
Camber Pharmaceuticals Inc.
3 NDCs
$3.3773
avg/unit
Aurobindo Pharma Limited
3 NDCs
$0.6733
avg/unit
Macleods Pharmaceuticals Limited
2 NDCs
$0.8639
avg/unit
Strides Pharma Inc.
2 NDCs
$0.8639
avg/unit
Ingenus Pharmaceuticals LLC
1 NDC
$0.9893
avg/unit
Major Pharmaceuticals
1 NDC
$0.4359
avg/unit
American Health Packaging
1 NDC
$0.4359
avg/unit
Rising Pharma Holdings Inc.
1 NDC
$0.2389
avg/unit
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
EPIVIR 300 MG TABLET | $13.2940 per EA | — |
LAMIVUDINE HBV 100 MG TABLET | $9.0210 per EA | +1.67% |
LAMIVUDINE HBV 100 MG TABLET | $8.1597 per EA | — |
EPIVIR 150 MG TABLET | $6.6144 per EA | — |
LAMIVUDINE 300 MG TABLET | $1.3821 per EA | — |
LAMIVUDINE 300 MG TABLET | $1.3014 per EA | — |
LAMIVUDINE 300 MG TABLET | $1.2918 per EA | -3.28% |
LAMIVUDINE 300 MG TABLET | $1.2918 per EA | -3.28% |
LAMIVUDINE 300 MG TABLET | $1.2918 per EA | -3.28% |
LAMIVUDINE 150 MG TABLET | $0.9893 per EA | — |
LAMIVUDINE 150 MG TABLET | $0.5901 per EA | — |
LAMIVUDINE 150 MG TABLET | $0.4797 per EA | — |
EPIVIR 10 MG/ML ORAL SOLN | $0.4452 per ML | — |
LAMIVUDINE 150 MG TABLET | $0.4359 per EA | +1.75% |
LAMIVUDINE 150 MG TABLET | $0.4359 per EA | +1.75% |
LAMIVUDINE 150 MG TABLET | $0.4359 per EA | +1.75% |
LAMIVUDINE 150 MG TABLET | $0.4359 per EA | +1.75% |
LAMIVUDINE 150 MG TABLET | $0.4359 per EA | +1.75% |
LAMIVUDINE 10 MG/ML ORAL SOLN | $0.2389 per ML | -4.25% |
LAMIVUDINE 10 MG/ML ORAL SOLN | $0.2389 per ML | -4.25% |